Quantitative Systems Pharmacology approaches for immuno‐oncology: adding virtual patients to the development paradigm Publication Quantitative Systems Pharmacology approaches for immuno‐oncology: adding virtual patients to the development paradigm Drug development in oncology commonly exploits the tools of molecular biology to gain therapeutic benefit…Certara2020年7月26日
Model‐Informed Drug Repurposing: Viral Kinetic Modeling to Prioritize Rational Drug Combinations for COVID‐19 Publication Model‐Informed Drug Repurposing: Viral Kinetic Modeling to Prioritize Rational Drug Combinations for COVID‐19 We hypothesized that viral kinetic modeling could be helpful to prioritize rational drug combinations for…Certara2020年7月26日
Salvaging CNS Clinical Trials Halted Due to COVID‐19 Publication Salvaging CNS Clinical Trials Halted Due to COVID‐19 The coronavirus disease 2019 (COVID‐19) pandemic has halted many ongoing central nervous system (CNS) clinical…Certara2020年7月15日
Mechanistic quantitative pharmacology strategies for the early clinical development of bispecific antibodies in oncology Publication Mechanistic quantitative pharmacology strategies for the early clinical development of bispecific antibodies in oncology Bispecific antibodies (bsAbs) have become an integral component of the therapeutic research strategy to treat…Certara2020年7月14日
VIVD: Virtual in vitro distribution model for the mechanistic prediction of intracellular concentrations of chemicals in in vitro toxicity assays Publication VIVD: Virtual in vitro distribution model for the mechanistic prediction of intracellular concentrations of chemicals in in vitro toxicity assays Certara2020年6月28日
Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110 Publication Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110 Certara2020年1月17日
Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing Publication Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal DosingCertara2020年1月17日
Precision Dosing in Clinical Medicine: Present and Future Publication Precision Dosing in Clinical Medicine: Present and Future Certara2018年7月20日
A Population Pharmacokinetic Model for a Solid Oral Tablet Formulation of Posaconazole Publication A Population Pharmacokinetic Model for a Solid Oral Tablet Formulation of Posaconazole Certara2018年7月1日
Pharmacodynamic Analysis of Eribulin Safety in Breast Cancer Patients Using Real-world Postmarketing Surveillance Data Publication Pharmacodynamic Analysis of Eribulin Safety in Breast Cancer Patients Using Real-world Postmarketing Surveillance Data Certara2018年6月22日